Korean Stock Flows

Bio Note (KRX: 377740)

바이오노트 KOSPI Biotech & Pharma 의료용품 및 기타 의약 관련제품 제조업
Close (Oct 13, 2026)
₩4,615
0.00%
Market cap
₩0T ($0.4B)
52-week range
₩4,050 – ₩6,260
P/E (trailing) · P/B · Div yield
– · 0.31 · 4.94%

Who is buying Bio Note?

Between Sep 10, 2026 and Oct 13, 2026 (20 trading sessions), foreign investors net sold ₩0.1bn ($0M) of Bio Note, the 431st largest foreign net sale among 832 KOSPI stocks. Institutions net sold ₩0.0bn ($0M) and retail investors net bought ₩0.1bn ($0M) over the same window. Foreigners were net buyers on 8 of the 20 sessions.

Foreign investors hold 0.48% of Bio Note's listed shares (KRX ownership data as of Oct 13, 2026), down from 0.54% twenty sessions earlier and 0.65% a year ago.

The stock closed at ₩4,615 on Oct 13, 2026: -2.74% over 20 sessions, -15.63% year-to-date, -20.98% over one year. The 52-week range is ₩4,050 – ₩6,260.

Bio Note share price, last 60 trading days (KRW)
5,005 4,787 4,568 4,350 Jul 13 Aug 26 Oct 13
Daily foreign investor net purchases, last 60 trading days
+0.3bn +0.1bn -0.1bn -0.3bn Jul 13 Aug 26 Oct 13
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-13 ₩4,615 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-10-12 ₩4,615 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-10-08 ₩4,640 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-10-07 ₩4,700 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-10-06 ₩4,640 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-10-02 ₩4,700 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-10-01 ₩4,695 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-09-30 ₩4,675 +₩0.1bn ₩-0.0bn ₩-0.0bn
2026-09-29 ₩4,645 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-09-28 ₩4,660 +₩0.0bn +₩0.0bn ₩0.0bn
2026-09-23 ₩4,645 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-22 ₩4,670 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-09-21 ₩4,650 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-09-18 ₩4,655 ₩-0.1bn ₩-0.0bn +₩0.0bn
2026-09-17 ₩4,715 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-09-16 ₩4,710 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-09-15 ₩4,730 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-09-14 ₩4,760 +₩0.1bn ₩-0.0bn ₩-0.0bn
2026-09-11 ₩4,760 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-09-10 ₩4,765 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-09-09 ₩4,745 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-09-08 ₩4,680 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-09-07 ₩4,780 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-09-04 ₩4,790 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-09-03 ₩4,800 ₩-0.0bn +₩0.0bn ₩-0.0bn
2026-09-02 ₩4,765 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-09-01 ₩4,800 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-08-31 ₩4,770 ₩0.0bn +₩0.0bn ₩-0.0bn
2026-08-28 ₩4,800 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-08-27 ₩4,750 ₩-0.2bn ₩-0.0bn +₩0.2bn
2026-08-26 ₩4,840 +₩0.0bn ₩-0.1bn +₩0.0bn
2026-08-25 ₩4,815 +₩0.0bn ₩-0.1bn +₩0.1bn
2026-08-24 ₩4,955 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-21 ₩4,835 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-08-20 ₩4,840 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-08-19 ₩4,865 ₩-0.1bn +₩0.0bn +₩0.0bn
2026-08-18 ₩4,910 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-08-14 ₩4,930 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-08-13 ₩4,900 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-08-12 ₩4,925 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-08-11 ₩4,970 ₩-0.1bn +₩0.1bn ₩-0.1bn
2026-08-10 ₩4,900 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-08-07 ₩4,845 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-06 ₩4,755 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-08-05 ₩4,625 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-04 ₩4,520 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-08-03 ₩4,570 +₩0.0bn +₩0.0bn ₩-0.1bn
2026-07-31 ₩4,555 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-07-30 ₩4,430 ₩-0.0bn +₩0.0bn ₩-0.0bn
2026-07-29 ₩4,445 +₩0.0bn +₩0.0bn ₩-0.1bn
2026-07-28 ₩4,405 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-07-27 ₩4,630 +₩0.0bn +₩0.0bn ₩-0.1bn
2026-07-24 ₩4,570 +₩0.1bn +₩0.0bn ₩-0.0bn
2026-07-23 ₩4,570 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-07-22 ₩4,385 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-07-21 ₩4,435 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-07-20 ₩4,560 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-07-16 ₩4,700 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-07-15 ₩4,675 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-07-14 ₩4,580 +₩0.3bn ₩-0.0bn ₩-0.3bn
2026-07-13 ₩4,580 ₩-0.0bn ₩-0.0bn +₩0.0bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day +₩0.1bn +$0M +₩0.0bn ₩-0.1bn
5 days ₩-0.0bn $-0M +₩0.0bn ₩-0.1bn
20 days ₩-0.1bn $-0M ₩-0.0bn +₩0.1bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying Bio Note stock?

Over the last 5 sessions foreign investors net sold ₩0.0bn ($0M) of Bio Note; over 60 sessions they net sold ₩0.2bn ($0M); since Jan 1, 2026 they net sold ₩1.8bn ($1M). Over 20 sessions the stock is the 431st largest foreign net sale among 832 KOSPI stocks.

How much of Bio Note do foreign investors own?

Foreign investors own 0.48% of Bio Note's shares as of Oct 13, 2026, versus 0.65% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net sold ₩0.0bn ($0M) and retail investors net bought ₩0.1bn ($0M) of Bio Note. Retail investors have been absorbing what foreigners and institutions are selling.

Is Bio Note listed on KOSPI or KOSDAQ?

Bio Note (바이오노트) trades on KOSPI under KRX code 377740 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.4B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2023 ₩90bn ($68M) – -₩47bn (-$35M) -₩20bn (-$15M)
2024 ₩103bn ($77M) +14.10% ₩12bn ($9M) ₩55bn ($41M)
2025 ₩118bn ($89M) +15.10% ₩17bn ($13M) -₩87bn (-$66M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1333.09/$) for reference only.

← All foreign investor flows